These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25714535)

  • 41. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
    Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
    Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance.
    Woo SJ; Han JM; Ahn J; Heo JW; Yu HG; Chung H; Song J; Park KU; Park KH
    Retina; 2012 Apr; 32(4):667-71. PubMed ID: 22307220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration.
    Moshfeghi AA
    Semin Ophthalmol; 2011 May; 26(3):139-48. PubMed ID: 21609227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-month results.
    Cleary CA; Jungkim S; Ravikumar K; Kelliher C; Acheson RW; Hickey-Dwyer M
    Eye (Lond); 2008 Jan; 22(1):82-6. PubMed ID: 17891059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
    Fung AE; Lalwani GA; Rosenfeld PJ; Dubovy SR; Michels S; Feuer WJ; Puliafito CA; Davis JL; Flynn HW; Esquiabro M
    Am J Ophthalmol; 2007 Apr; 143(4):566-83. PubMed ID: 17386270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration.
    Singer MA; Awh CC; Sadda S; Freeman WR; Antoszyk AN; Wong P; Tuomi L
    Ophthalmology; 2012 Jun; 119(6):1175-83. PubMed ID: 22306121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravitreal injection of ranibizumab for treatment of age-related macular degeneration: effects on serum VEGF concentration.
    Gu X; Yu X; Dai H
    Curr Eye Res; 2014 May; 39(5):518-21. PubMed ID: 24215127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. All India Ophthalmological Society members' survey: Practice pattern of intravitreal anti-vascular endothelial growth factor injection.
    Sundar D; Das T; Chhablani J; Kumar A; Sharma N
    Indian J Ophthalmol; 2020 Jun; 68(6):1095-1098. PubMed ID: 32461437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease.
    Wong LJ; Desai RU; Jain A; Feliciano D; Moshfeghi DM; Sanislo SR; Blumenkranz MS
    Retina; 2008 Oct; 28(8):1151-8. PubMed ID: 18685542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of lidocaine gel anesthesia on endophthalmitis rates following intravitreal injection.
    Lad EM; Maltenfort MG; Leng T
    Ophthalmic Surg Lasers Imaging; 2012; 43(2):115-20. PubMed ID: 22283227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Real-World Trends in Intravitreal Injection Practices among American Retina Specialists.
    Chaturvedi R; Wannamaker KW; Riviere PJ; Khanani AM; Wykoff CC; Chao DL
    Ophthalmol Retina; 2019 Aug; 3(8):656-662. PubMed ID: 31133544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of acute endophthalmitis after intravitreal bevacizumab injection in a single clinical center.
    Falavarjani KG; Modarres M; Hashemi M; Parvaresh MM; Naseripour M; Zare-Moghaddam A; Nekoozadeh S
    Retina; 2013 May; 33(5):971-4. PubMed ID: 23400076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
    Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
    Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical proparacaine eye drops to improve the experience of patients undergoing intravitreal injections: A randomized controlled trial.
    Reynolds MM; Mercill SL; Wirkus AL; Greenwood Quaintance K; Pulido JS
    Eur J Ophthalmol; 2020 Nov; 30(6):1454-1460. PubMed ID: 31983237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Translational public health care perspective: intravitreal treatment of neovascular age-related macular degeneration has revolutionized clinical ophthalmology.
    Bloch SB; Larsen M
    Acta Ophthalmol; 2015 Mar; 93(2):103-4. PubMed ID: 25688486
    [No Abstract]   [Full Text] [Related]  

  • 56. Treat-and-extend bevacizumab for neovascular age-related macular degeneration: the importance of baseline characteristics.
    Rush RB; Simunovic MP; Vandiver L; Aragon AV; Ysasaga JE
    Retina; 2014 May; 34(5):846-52. PubMed ID: 24240560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visual results following intravitreal Bevacizumab in neovascular age-related macular degeneration.
    Iqbal K; Baig J; Jamil AZ; Jamil H; Mirza K; Khan T
    J Coll Physicians Surg Pak; 2011 Sep; 21(9):535-8. PubMed ID: 21914409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
    Papadopoulou DN; Mendrinos E; Mangioris G; Donati G; Pournaras CJ
    Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch.
    Yamashiro K; Tsujikawa A; Miyamoto K; Oh H; Otani A; Tamuara H; Ooto S; Sasahara M; Iwama D; Yoshimura N
    Retina; 2010 Mar; 30(3):485-90. PubMed ID: 19952993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistent elevation of intraocular pressure following intravitreal injection of bevacizumab.
    Segal O; Ferencz JR; Cohen P; Nemet AY; Nesher R
    Isr Med Assoc J; 2013 Jul; 15(7):352-5. PubMed ID: 23943979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.